Not many years have passed since chronic ear disease with cholesteatoma presented a grave threat to life. A big step forward was recognition of the need for surgical drainage and its logical extension to exteriorization of disease. Improvements in technique and equipment together with the advent of antibiotics then allowed the otologist to progress from a desperate struggle to salvage the patient to the structured surgical approach of today in which the aim is to preserve undamaged and salvageable tissue and reconstruct where possible.
There is still some debate as to the nature of cholesteatoma, but a more accurate term might be keratoma or epidermoid cyst. Regarding pathogenesis, the majority view probably now favours retraction of Shrapnel's membrane or the posterosuperior quadrant of the pars tensa, which develops into a gradually expanding cyst containing epithelial debris that has locally erosive properties.
Before discussing my own experiences in dealing with cholesteatoma let me clarify some definitions and clear up some misconceptions. First, a distinction between recurrent and residual cholesteatoma is crucial to the understanding and comparison of different surgical techniques. As Smyth1 stated: 'Recurrent cholesteatoma is the development of a new cholesteatoma. It takes the form of a retraction pocket similar to the original disease. Residual cholesteatoma arises from the failure to remove all of the original disease from the tubotympanic cleft'. According to the published work, the residual disease rate is much the same for open or closed techniques2-7. The high risk areas are in the middle ear-the sinus tympani and oval window and the attic, especially the anterior epitympanic area (Figure 1 ). These are all areas covered by grafting in any method other than a true radical exploration, hence the similarity in residual disease rates for open and closed techniques ( Figure 2 ). There is obviously considerable variation between the results of individual surgeons, and some have presented figures for both techniques. If the percentages are averaged (a statistically risky thing to do) the residual disease rate for closed cavities is 10 .2% and open cavities 11.4%, an unimpressive difference. Residual disease in the mastoid bowl itself is rare, as one might expect since it is the easiest area to access Now that the lethal complications11'12 which so concerned our predecessors are rare we can afford to concentrate on the symptoms that brought our patients to see us, namely chronic aural discharge and hearing loss. There should no longer be any excuse for the situation alluded to by Palva in 198213, who stated: 'patients with continuously discharging cavities are post-operatively in their opinion much worse off than they were pre-operatively'. Here I present the results of three surgical techniques I have used in the management of chronic middle ear disease with cholesteatoma. In the preoperative interview I stress to the patient that the aim of the procedure is to provide a dry, safe, trouble-free ear and that a hearing gain should be considered a bonus. The patient may well have satisfactory hearing on the other side, and even the most skilled otologist will struggle to equal a normal hearing ear when dealing with the damage inflicted by years of chronic ear disease. I have therefore avoided complex formulae and assessment of air-bone gaps; these may highlight the skill of the surgeon but probably bear little relation to patient benefit. I have looked at three aspects. The first is hearing in the opposite ear. The second, if the opposite ear is unsatisfactory, the hearing in the operated ear assessed by the 'Belfast rule of thumb'-hearing better than 30dB at 0.5, 1, 2 and 4kHz, or improved to within l5dB of the 
COMBINED-APPROACH TYMPANOPLASTY WITH BONE PATE REPAIR
The final technique relates to the more extensive cholesteatomas or to attic disease not suitable for atticotomy and bone pate repair. This combined-approach tympanoplasty method was developed over the past 20 years. The early attempts date from about the time of Gordon Smyth's historic warning on the limitations of the technique, and my aim has been to address the problems of residual and recurrent disease18. Residual disease responds satisfactorily to staging, provided that all the appropriate stages are strictly completed19'20 All patients are booked for a second-look operation after 12 months. If there is residual disease which is ruptured during removal, or is already diffuse, then a further stage is required. Latterly, the surgical laser has halved the incidence of residual disease and third-stage surgery has rarely been required, although only a minority of patients have been treated in this way.
Recurrence is not so easy to deal with21. After several years of trial and error with different methods for repairing the outer attic wall22-26, bone pate was found to be the most effective. It replaces bone with bone and can easily be added to or drilled away at subsequent stages, affording great surgical flexibility.
In conjunction with the canal wall repair, ventilation of the middle ear and mastoid is crucial. The use of silastic sheet from the mastoid through the attic and posterior tympanotomy into the middle ear ventilates the lower route, the roof of the attic to the anterior epitympanic cell and back into the middle ear provides a superior ventilation route. In addition to supporting the bone pate repair the silastic prevents adhesions between the tympanic membrane and the medial wall of the middle ear and consequent tensa retraction. As in the atticotomy technique, the bone pate is stabilized with fibrin glue (Figure 3) .
A total of 300 patients have been treated by combinedapproach tympanoplasty with bone pate repair. There has been a 90% follow-up rate, from 1 to 16 years (mean 8 years). Residual cholesteatoma was found at the second stage (after 12 months) in 61 cases (20%). Most of this residual disease takes the form of discrete epithelial pearls which can be dissected out intact. Some, however, rupture on removal or are already diffuse and a further stage is then necessary. 38 patients (12.7%) have required a third stage to eliminate disease and eight (2.7%) have gone on to a fourth operation. Of the 95 patients in whom a laser was used, only three (3.2%) have required a third stage and none a fourth stage. At the second stage the attic repair is carefully checked. Retraction pockets are visible permeatally in less than 5%, while elevation of the tympanomeatal flat reveals additional areas of inadequate bone repair in another 8%; further bone pate is used to eliminate these defects. Cholesteatoma has recurred in six patients to date, all between 2 and 6 years postoperatively; all six have had a repeat combined-approach tympanoplasty and are well with stable ears. Thus repair of the attic defects with bone dust, with a check and if necessary reinforcement at 12 months, seems to confer lasting stability in this otherwise unstable area. There have been a small number13 of subsequent operations for ossiculoplasty and myringoplasty and overall the average number of operations for the 300 patients has been 2.2. Current evaluation reveals 12 patients in whom the attic is not ideal. These patients are under regular review and any sign of instability will signal the need for reinforcement surgery. It is noteworthy that only four patients have been converted to an open cavity. I like to think that this answers the criticism that combined-approach tympanoplasty is nothing more than a two-stage open-cavity mastoidectomy.
With regard to the hearing results of combined-approach tympanoplasty, the 300 patients have 215 normal contralateral ears. Of the 85 patients who did not have normal hearing on the other side, five had dead ears preoperatively and hence could not benefit; 36 operated ears satisfied the Belfast rule of thumb, and a further 27 were satisfactorily aided, leaving 17 with disability not helped by surgery.
CONCLUSIONS
If the results of these three techniques are combined, wet ears are present in just under 2% of cases and a hearing handicap persists in a little over 5%. Palva28 suggests that a cholesteatoma recurrence rate of less than 10% is satisfactory. If the cholesteatoma recurrence rate in this series is added to the figures for persistent discharge and hearing handicap the total equates to 9%. These surgical techniques for cholesteatoma therefore not only control the underlying disease but also resolve the presenting symptoms, with a failure rate of less than 10%.
